Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients

HIGHLIGHTS: What are the main findings? Our objective was to determine the relationship between the methionine synthase reductase polymorphisms (MTRR and MTR) and the risk of developing chronic myeloid leukemia (CML) in Sudanese Patients. What is the implication of the main finding? Here, we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Elderdery, Abozer Y., Tebein, Entesar M., Alenazy, Fawaz O., Elkhalifa, Ahmed M. E., Shalabi, Manar G., Abbas, Anass M., Alhassan, Hassan H., Davuljigari, Chand B., Mills, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602384/
https://www.ncbi.nlm.nih.gov/pubmed/36292614
http://dx.doi.org/10.3390/genes13101729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602384/
https://www.ncbi.nlm.nih.gov/pubmed/36292614
http://dx.doi.org/10.3390/genes13101729

Ejemplares similares